切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Sulfonylurea receptors - Insulin and Insulin-like Receptors - insulin - RET

11件产品中的 1-10

页面
每页
清除全部
  1. Tolbutamide
    B2194 Tolbutamide
    中文名: 甲苯磺丁脲
    Target: cAMP|Sulfonylurea receptors
    Summary: 第一代钾通道阻滞剂
      ≥10.05 mg/mL
      insoluble in H2O
  2. GSK1838705A
    A8440 GSK1838705A
    Target: Insulin and Insulin-like Receptors|ALK
    Summary: ATP竞争性IGF-IR/IR/ALK抑制剂
      ≥26.65 mg/mL
      insoluble in H2O
  3. PD168393
    A2024 PD168393
    Target: PDGFR|FGFR|EGFR|PKC|insulin
    Summary: EGFR抑制剂
      ≥18.45 mg/mL
      insoluble in H2O
  4. GSK1904529A
    A1302 GSK1904529A
    Target: Insulin and Insulin-like Receptors
    Summary: IGF-1R/IR 选择性抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  5. Lenvatinib (E7080)
    A2174 Lenvatinib (E7080)
    中文名: 乐伐替尼,仑伐替尼
    Target: VEGFR|PDGFR|RET
    Summary: VEGFR抑制剂
      ≥21.35 mg/mL
      insoluble in H2O
  6. BMS-754807
    A1185 BMS-754807
    Target: Insulin and Insulin-like Receptors
    Summary: 有效的、选择性的IGF-1R和InsR抑制剂
      ≥23.05 mg/mL
      insoluble in H2O
  7. Regorafenib
    A8236 Regorafenib
     4 Citation
    中文名: 瑞戈非尼
    Target: Raf|VEGFR|PDGFR|c-Kit|RET
    Summary: VEGFR/PDGFR/FGFR/mutant Kit/RET/Raf-1抑制剂
      ≥25.04 mg/mL
      insoluble in H2O
  8. MK 0893
    A3608 MK 0893
    Target: Insulin and Insulin-like Receptors|Glucagon Receptors
    Summary: 胰高血糖素受体/ IGF-1R拮抗剂
      ≥24.05 mg/mL
      insoluble in H2O
  9. AST 487
    A3194 AST 487
     1 Citation
    Target: RET
    Summary: RET激酶抑制剂
      ≥26.5 mg/mL
      insoluble in H2O
  10. Rosiglitazone maleate
    A4302 Rosiglitazone maleate
    中文名: 马来酸罗格列酮
    Target: Insulin and Insulin-like Receptors
    Summary: PPARγ激动剂,有效的胰岛素敏化剂
      ≥23.7 mg/mL
      insoluble in H2O

11件产品中的 1-10

页面
每页